Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis

ACC Souza, JWP Borges, TMM Moreira - Revista de saude publica, 2016 - SciELO Brasil
ABSTRACT OBJECTIVE To verify the effects of antihypertensive treatment (pharmacological
and non-pharmacological) on the health-related quality of life of individuals with …

Vasodilating β-adrenoceptor blockers as cardiovascular therapeutics

N Toda - Pharmacology & therapeutics, 2003 - Elsevier
β-Adrenoceptor blocking agents (β-blockers) have been established as therapeutics for
treatment of patients with hypertension, ischemic heart diseases, chronic heart failure …

Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure

JP Baguet, B Legallicier, P Auquier, S Robitail - Clinical Drug Investigation, 2007 - Springer
Background and objective: Despite advances in the treatment of hypertension, control rates
continue to be suboptimal in both Europe and the US. Strategies that improve hypertension …

The future of antihypertensive treatment

ZH Israili, R Hernández-Hernández… - American journal of …, 2007 - journals.lww.com
Despite progress in recent years in the prevention, detection, and treatment of high blood
pressure (BP), hypertension remains an important public health challenge. Hypertension …

A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure

JP Baguet, S Robitail, L Boyer, D Debensason… - American journal of …, 2005 - Springer
Introduction: Hypertension constitutes a veritable public health issue. Several classes of
drugs are available for the treatment of hypertension. The objective of this meta-analytical …

Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats

J Srinivasan, B Suresh, M Ramanathan - Physiology & behavior, 2003 - Elsevier
The effect of angiotensin-converting enzyme (ACE) inhibitor enalapril (EPL)(2 and 4 mg/kg),
angiotensin (AT) II receptor antagonist losartan (LRN)(5 and 10 mg/kg), and anxiolytic drug …

[HTML][HTML] Erectile dysfunction: does insulin resistance play a part?

JC Trussell, RS Legro - Fertility and sterility, 2007 - Elsevier
OBJECTIVE: To review MEDLINE literature for correlations between insulin resistance and
erectile dysfunction (ED). DESIGN: MEDLINE literature review (1966 to present). SETTING …

Qualidade de vida e adesão ao tratamento em hipertensão: revisão sistemática com metanálise

ACC Souza, JWP Borges… - Revista de Saúde …, 2016 - SciELO Public Health
RESUMO OBJETIVO: Verificar os efeitos do tratamento anti-hipertensivo (farmacológico e
não-farmacológico) na qualidade de vida relacionada à saúde de pessoas com hipertensão …

Качество жизни у больных гипертонической болезнью на фоне терапии рилменидином в сравнении с атенололом

ЮР Кашерининов, АА Шаваров… - Артериальная …, 2004 - cyberleninka.ru
В работе оценивалось влияние 26-недельной терапии рилменидином в дозе 1-2 мг в
сутки и атенололом в дозе 50-100 мг в сутки на показатели качества жизни …

Management of erectile dysfunction: an under-recognition of hypertension

G Koroglu, E Kaya-Sezginer… - Current …, 2018 - ingentaconnect.com
Background: Erectile dysfunction (ED) affects 30 million men in the US with a decrease in
quality of life. Thirty percent of hypertensive men suffer from ED. Objective: This review will …